Practice Location

3509 22ND ST
LUBBOCK, TX 79410-1307

Phone: (806) 799-7928

What does CRAIG RHYNE research?

Dr. Rhyne studies two main areas: chronic migraine management and dark matter detection. In the realm of migraine, he investigates treatments such as onabotulinumtoxinA (commonly known as Botox) and erenumab to understand their safety and effectiveness in patients suffering from this debilitating condition. He examines how these treatments affect quality of life and the challenges of medication adherence, especially for patients using multiple therapies. For dark matter, he works on enhancing the detection capabilities of experimental setups like the Large Underground Xenon (LUX) experiment, focusing on understanding elusive particles and their interactions with normal matter. His findings contribute significantly to the ongoing search for dark matter and its properties.

Key findings

  • In a study involving 183 patients, 23.5% experienced side effects from onabotulinumtoxinA, with no serious safety concerns found.
  • Over a two-year evaluation of 279 patients, approximately 29% reported side effects from onabotulinumtoxinA, confirming its safety across multiple therapeutic indications.
  • A study on chronic migraine treatments found that 70% of patients stopped using erenumab within a year, highlighting adherence challenges.
  • Patients given a combination of atogepant and onabotulinumtoxinA experienced a drop in headache days from 24 to 15.85, with over 45% reducing their headache days by half within three months.
  • More than 1 billion people suffer from migraines, and new treatments using monoclonal antibodies offer significant improvements in headache management.

Frequently asked questions

Does Dr. Rhyne study migraine conditions?
Yes, Dr. Rhyne focuses extensively on chronic migraine treatments and their effectiveness.
What treatments has Dr. Rhyne researched for migraines?
He has researched treatments like onabotulinumtoxinA, erenumab, and atogepant, among others.
Is Dr. Rhyne's work relevant to patients with chronic migraines?
Yes, his research directly helps patients by assessing the safety and effectiveness of various treatment options.
What is Dr. Rhyne's involvement in dark matter research?
He works on experiments that search for dark matter particles, aiming to improve detection methods and understand their properties.
How does Dr. Rhyne's research impact science?
His findings contribute to our understanding of both chronic migraine management and the fundamental nature of dark matter in the universe.

Publications in plain English

Two-year real-world retrospective safety evaluation with onabotulinumtoxinA across multiple therapeutic indications: Findings from the SYNCHRONIZE study.

2026

Toxicon : official journal of the International Society on Toxinology

Forde G, Ifantides KB, Mayadev A, Patel AT, Rhyne C +6 more

Plain English
This study looked at the safety of a treatment called onabotulinumtoxinA, commonly used for various health issues, over a two-year period in patients receiving it for multiple conditions. Researchers followed 279 patients and found that about 29% experienced at least one side effect, such as urinary tract infections or neck pain, which is consistent with past findings for this treatment. Importantly, no new safety concerns were identified, indicating that onabotulinumtoxinA can be safely used for different health problems over time. Who this helps: This helps patients using onabotulinumtoxinA for multiple conditions and their healthcare providers.

PubMed

Real-World Retrospective Safety Analysis of OnabotulinumtoxinA for the Treatment of Patients with Chronic Migraine and Concomitant Therapeutic Indications.

2026

Pain and therapy

Blumenfeld AM, Rhyne C, Martinez K, Patel A, Becker Ifantides K +5 more

Plain English
This study looked at the safety of using onabotulinumtoxinA (commonly known as Botox) for treating chronic migraine along with other health issues in patients. Researchers found that of 183 patients treated, 23.5% experienced side effects within six months, with the most frequent being neck pain (6.6%) and headache (4.9%). Importantly, there were no serious new safety concerns identified, indicating that this treatment approach is safe for patients with multiple conditions. Who this helps: Patients with chronic migraines and additional health issues who are considering this treatment.

PubMed

Changes in use of acute and preventive medications for migraine after erenumab initiation over 12 months: A United States retrospective cohort study.

2025

Headache

Multani JK, Urman R, Park AS, Gill K, Vuvu F +6 more

Plain English
This study examined how adults in the U.S. used medications for migraine after starting a new treatment called erenumab over the course of a year. It found that 70% of patients stopped using erenumab, and many continued to use their previous migraine medications but also discontinued some of them—56.7% for acute medications and 46.7% for traditional preventive medications. This matters because it highlights the challenges patients face in sticking with these treatments, which can impact their ability to manage migraine effectively. Who this helps: Patients suffering from migraines.

PubMed

Correction to: Real‑World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review.

2025

Pain and therapy

Blumenfeld AM, Mechtler L, Cook L, Rhyne C, Jenkins B +4 more

PubMed

Nuclear Recoil Calibration at Sub-keV Energies in LUX and Its Impact on Dark Matter Search Sensitivity.

2025

Physical review letters

Akerib DS, Alsum S, Araújo HM, Bai X, Balajthy J +91 more

Plain English
This research explored how well a special type of detector, called a dual-phase xenon time projection chamber (TPC), can spot very light dark matter particles. The scientists tested its response to low-energy nuclear recoils, finding it could detect signals as small as 0.45 keV of light and 0.27 keV of charge. These findings are important because they improve our ability to search for low-mass dark matter, which has been difficult to detect so far. Who this helps: This benefits researchers and scientists studying dark matter and the fundamental nature of the universe.

PubMed

Real-World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review.

2024

Pain and therapy

Blumenfeld AM, Mechtler L, Cook L, Rhyne C, Jenkins B +4 more

Plain English
This study looked at how well the combination of two treatments—atogepant and onabotulinumtoxinA—works for preventing chronic migraines. Researchers found that patients experienced a significant drop in the number of headache days: from an average of 24 days to 15.85 days after adding atogepant, leading to over 45% of patients reducing their headache days by half within about three months. This is important because it shows that combining these two treatments can provide more relief for people suffering from chronic migraines without new safety concerns. Who this helps: Patients suffering from chronic migraines benefit from this treatment combination.

PubMed

SYNCHRONIZE: Real-World Retrospective Safety Analysis of Patients Treated with OnabotulinumtoxinA for More than One Therapeutic Indication.

2024

Toxins

Forde G, Brucker BM, Becker Ifantides K, Patel AT, Mayadev A +9 more

Plain English
This study examined the safety of a medication known as OnabotulinumtoxinA, when used to treat patients for more than one condition at the same time. Researchers looked at the medical records of 279 patients and found that 28.7% experienced at least one side effect, such as urinary tract infections (5.7%) or neck pain (5.0%), which are similar to those seen with individual treatments. The findings matter because they provide reassurance about the safety of using this medication for multiple conditions without any new safety concerns arising. Who this helps: This helps patients managing multiple health conditions and their doctors.

PubMed

ortholog of theMuller D element.

2024

microPublication biology

Mo M, Sabb D, LoBello L, Chambers K, Kershaw K +7 more

Plain English
This research focused on a specific gene known as the ortholog of the absent, small, or homeotic discs 1. The study found that this gene has two different versions, which were shown to include extra amino acids in one form and has certain features that suggest it is important for functioning properly. Understanding these genetic details is crucial because they can help researchers learn more about how this gene works and its role in health or disease. Who this helps: This helps researchers studying genetics and potentially patients with related health conditions.

PubMed

Burden of migraine with acute medication overuse or psychiatric comorbidities and treatment with CGRP pathway-targeted monoclonal antibodies: A review.

2023

Medicine

Rhyne C, Cohen JM, Seminerio MJ, Carr K, Krasenbaum LJ

Plain English
This study looked at how migraines affect people, especially those who often overuse pain medication or have mental health issues like depression or anxiety. It found that over 1 billion people suffer from migraines, which can significantly impact their lives. New treatments, specifically monoclonal antibodies targeting a pathway involved in migraines, have been shown to reduce the number of headache days and improve quality of life for patients. Who this helps: This helps patients suffering from migraines, especially those struggling with medication overuse or psychiatric conditions.

PubMed

Results of a Search for Sub-GeV Dark Matter Using 2013 LUX Data.

2019

Physical review letters

Akerib DS, Alsum S, Araújo HM, Bai X, Balajthy J +94 more

Plain English
This research focused on detecting dark matter particles that are very light, specifically those weighing between 0.4 and 5 GeV. By using data from a 2013 experiment, the researchers found new ways to identify interactions between these dark matter particles and regular matter, revealing that liquid xenon detectors can capture signals previously thought undetectable. This study opens up new possibilities for dark matter searches, helping us learn more about the universe's hidden components. Who this helps: This helps researchers and scientists studying dark matter and the fundamental nature of the universe.

PubMed

Results from a Search for Dark Matter in the Complete LUX Exposure.

2017

Physical review letters

Akerib DS, Alsum S, Araújo HM, Bai X, Bailey AJ +97 more

Plain English
In this research, scientists used the Large Underground Xenon (LUX) experiment to search for a type of dark matter called WIMPs (weakly interacting massive particles) to see if they could detect their interaction with regular matter. They found no evidence of these particles, meaning that WIMPs with a mass around 50 GeV cannot interact with normal matter at levels above a certain threshold, specifically excluding interactions above 2.2 × 10^-46 cm². This finding is important because it helps refine our understanding of dark matter and how it behaves, providing clearer limits on what scientists should look for in future studies. Who this helps: This helps researchers and scientists investigating dark matter.

PubMed

Limits on Spin-Dependent WIMP-Nucleon Cross Section Obtained from the Complete LUX Exposure.

2017

Physical review letters

Akerib DS, Alsum S, Araújo HM, Bai X, Bailey AJ +95 more

Plain English
This study focused on measuring the interactions between a hypothetical particle called a WIMP (Weakly Interacting Massive Particle) and regular matter, specifically neutrons and protons. The researchers found that the interaction strength is much weaker than previously thought, setting new upper limits at 1.6 x 10^-41 cm² for neutrons and 5 x 10^-40 cm² for protons. This matters because it helps scientists better understand dark matter, which makes up a significant part of the universe but remains elusive. Who this helps: This helps researchers studying dark matter and its properties.

PubMed

First Searches for Axions and Axionlike Particles with the LUX Experiment.

2017

Physical review letters

Akerib DS, Alsum S, Aquino C, Araújo HM, Bai X +97 more

Plain English
This study focused on searching for elusive particles called axions and axionlike particles using a special experiment called the Large Underground Xenon (LUX) experiment. The researchers found that the ability of these particles to interact with electrons in xenon is extremely limited; specifically, for solar axions, they showed that this interaction strength, known as g_{Ae}, is less than 3.5 x 10^-12, and they set a maximum mass for axions at 0.12 eV/c². This research is important because it helps scientists narrow down the properties of these theoretical particles, which could play a role in understanding dark matter and the universe. Who this helps: This helps physicists and researchers studying dark matter and particle physics.

PubMed

Improved Limits on Scattering of Weakly Interacting Massive Particles from Reanalysis of 2013 LUX Data.

2016

Physical review letters

Akerib DS, Araújo HM, Bai X, Bailey AJ, Balajthy J +97 more

Plain English
This research looked at a type of potential dark matter particle called weakly interacting massive particles (WIMPs) using data from the Large Underground Xenon experiment collected in 2013. The study found new limits on how often WIMPs might scatter off normal matter, concluding that the maximum chance of this happening is 0.6 zeptobarns at a WIMP mass of 33 GeV/c². This finding is important because it helps scientists better understand dark matter's behavior and properties, aiding in the search for these elusive particles. Who this helps: This helps researchers searching for dark matter.

PubMed

Results on the Spin-Dependent Scattering of Weakly Interacting Massive Particles on Nucleons from the Run 3 Data of the LUX Experiment.

2016

Physical review letters

Akerib DS, Araújo HM, Bai X, Bailey AJ, Balajthy J +97 more

Plain English
This study looked at how weakly interacting massive particles (WIMPs), which are candidates for dark matter, interact with nucleons (the building blocks of atomic nuclei) using data from the LUX experiment. The researchers found upper limits on the interaction strength, showing that WIMPs collide with neutrons at a rate less than 9.4 x 10^-41 cm² and with protons at less than 2.9 x 10^-39 cm² for particles weighing around 33 GeV/c². This is important because it narrows down our understanding of dark matter interactions and helps physicists detect and study these elusive particles more effectively. Who this helps: This helps researchers studying dark matter and its properties.

PubMed

Psychiatric consultation to a state board of medical examiners.

1991

The American journal of psychiatry

Bloom JD, Resnick M, Ulwelling JJ, Shore JH, Williams MH +1 more

Plain English
This study looked at how psychiatric consultations help the Oregon Board of Medical Examiners in evaluating doctors who may have mental health or substance abuse issues, or who might be misprescribing medications or abusing patients. The authors found that these consultations are effective and beneficial, significantly improving the situation for many doctors and their patients. This matters because it helps maintain high medical standards and ensures safer care for patients. Who this helps: This helps patients and doctors by promoting better mental health support and accountability in the medical field.

PubMed

Physicians investigated for inappropriate prescribing by the Oregon Board of Medical Examiners.

1989

The Western journal of medicine

Kofoed L, Bloom JD, Williams MH, Rhyne C, Resnick M

Plain English
This study looked at complaints against doctors for writing inappropriate prescriptions in Oregon between 1981 and 1986. The researchers found that over half of all investigations (51%) were due to this issue, mainly involving controlled substances like opioid painkillers and anxiety medications. Out of 130 doctors investigated, more than half had a history of complaints, and 50 were disciplined, indicating that problematic prescribing is often not noticed and happens repeatedly. Who this helps: This helps patients and healthcare professionals by promoting safer prescribing practices.

PubMed

The malpractice claims experience of physicians investigated for inappropriate prescribing.

1989

The Western journal of medicine

Bloom JD, Williams MH, Kofoed L, Rhyne C, Resnick M

Plain English
This study looked at 120 doctors in Oregon who were investigated for wrongly prescribing controlled substances, mainly painkillers and anxiety medications. Each of these doctors faced, on average, one malpractice claim, with obstetricians, neurosurgeons, and orthopedic surgeons having the most claims. The research highlights the need for state medical boards to review doctors who have been disciplined and received multiple malpractice claims, as this could improve patient safety. Who this helps: This helps patients by promoting better prescribing practices among doctors.

PubMed

Frequent Co-Authors

D S Akerib H M Araújo X Bai J Balajthy E P Bernard A Bernstein T P Biesiadzinski E M Boulton M C Carmona-Benitez C Chan

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.